Tumor M2-Pyruvate Kinase, Matrix Carbonic Anhydrase IX, and Metalloproteinase 9 — Novel Prognostic Markers of Renal Cell Carcinoma

The aim of the study was to assess the possibility of using plasma levels of tumor M2-pyruvate kinase (Tu M2-PK), matrix carbonic anhydrase IX (CA9), and matrix metalloproteinase 9 (MMP9) in patients with renal cell cancer as predictors of the disease course and the response to treatment. MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Amoev, Z.V., Alyasova, A.V., Gorshkova, T.N., Samsonova, E.I., Strokina, E.V., Kontorshchikova, K.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Privolzhsky Research Medical University 2020
Materias:
Biotechnologies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353685/
https://www.ncbi.nlm.nih.gov/pubmed/34513052
http://dx.doi.org/10.17691/stm2020.12.2.05

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353685/
https://www.ncbi.nlm.nih.gov/pubmed/34513052
http://dx.doi.org/10.17691/stm2020.12.2.05

Ejemplares similares